These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6300248)

  • 1. Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response.
    Hashimura E; Shimizu F; Nishino T; Imagawa K; Tateishi K; Hamaoka T
    J Immunol Methods; 1982 Dec; 55(3):375-87. PubMed ID: 6300248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunization procedure for production of anti-cholecystokinin-specific antiserum of low cross-reactivity.
    Tateishi K; Hamaoka T; Sugiura N; Yanaihara C; Yanaihara N
    J Immunol Methods; 1981; 47(2):249-58. PubMed ID: 7320512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels.
    Jansen JB; Lamers CB
    J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides in rat brain immunoreactive for the amino terminus of cholecystokinin 33: distribution and chromatography.
    Han SP; Allard LR; Beinfeld MC
    Biochem Biophys Res Commun; 1987 Dec; 149(3):902-7. PubMed ID: 3426615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cholecystokinin radioimmunoassay using synthetic CCK-10 as immunogen.
    Turkelson CM; Dale WE; Reidelberger R; Solomon TE
    Regul Pept; 1986 Oct; 15(3):205-17. PubMed ID: 3786838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large molecular forms of cholecystokinin circulating in humans.
    Gaisano HY; Reilly W; Go VL; Olivero D; Miller LJ
    Pancreas; 1986; 1(2):148-53. PubMed ID: 2437562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate measurement of cholecystokinin in plasma.
    Rehfeld JF
    Clin Chem; 1998 May; 44(5):991-1001. PubMed ID: 9590372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antral gastrin cells with region-specific antisera.
    Larsson LI; Rehfeld JF
    J Histochem Cytochem; 1977 Dec; 25(12):1317-21. PubMed ID: 925341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular nature of cholecystokinin in plasma. An in vivo immunosorption study in rabbits.
    Rehfeld JF
    Scand J Gastroenterol; 1994 Feb; 29(2):110-21. PubMed ID: 8171278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of cholecystokinin-pancreozymin.
    Harvey RF; Dowsett L; Hartog M; Read AE
    Gut; 1974 Sep; 15(9):690-9. PubMed ID: 4435583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of cholecystokinin octapeptide using a new specific radioimmunoassay.
    Adrian TE; Bacarese-Hamilton AJ; Bloom SR
    Peptides; 1985; 6(1):11-6. PubMed ID: 3991357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and detection of anti-peptide antibody specificity is critically affected by the mode of hapten presentation.
    Moroder L; Papini A; Siglmüller G; Köcher K; Dörrer E; Schneider CH
    Biol Chem Hoppe Seyler; 1992 Jun; 373(6):315-21. PubMed ID: 1381185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reactivity of mononucleotides with cholecystokinin/gastrin antisera.
    Rehfeld JF
    Regul Pept; 1983 Apr; 6(1):33-41. PubMed ID: 6867379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of cholecystokinin: comparison of different tracers.
    Cantor P; Rehfeld JF
    J Immunol Methods; 1985 Sep; 82(1):47-55. PubMed ID: 2411820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically active gastrin/CCK-related peptides in the stomach of a reptile, Crocodylus niloticus; identified and characterized by immunochemical methods.
    Dimaline R; Rawdon BB; Brandes S; Andrew A; Loveridge JP
    Peptides; 1982; 3(6):977-84. PubMed ID: 7167403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonism by gastrin for a cholecystokinin receptor mediating pepsinogen secretion.
    Tang LH; Miller MD; Goldenring JR; Modlin IM; Hersey SJ
    Am J Physiol; 1993 Nov; 265(5 Pt 1):G865-72. PubMed ID: 8238515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme immunoassay for cholecystokinin octapeptide sulfate and its application.
    Yamamoto H; Kato T
    J Neurochem; 1986 Mar; 46(3):702-7. PubMed ID: 3081683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of pepsinogen release from isolated gastric glands by cholecystokininlike peptides.
    Hersey SJ; May D; Schyberg D
    Am J Physiol; 1983 Feb; 244(2):G192-7. PubMed ID: 6297314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.